Edoardo Airo

Pisa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Prognostic relevance of the right ventricular fractional area change to pulmonary artery systolic pressure ratio in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Prognostic relevance of the right ventricular fractional area change to pulmonary artery systolic pressure ratio in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Journal: International journal of cardiology

Published: May 13, 2026

Obstructive Sleep Apneas and Cardiovascular Diseases.

Obstructive Sleep Apneas and Cardiovascular Diseases.

Journal: Clocks & sleep

Published: April 08, 2026

Corrigendum to "Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)" [Vascular Pharmacology 162 (2026) 107585].

Corrigendum to "Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)" [Vascular Pharmacology 162 (2026) 107585].

Journal: Vascular pharmacology

Published: February 26, 2026

2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.

2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.

Journal: Vascular pharmacology

Published: December 20, 2025

Real-World Sotatercept Eligibility: Analysis from the FOCUS-PAH Registry.

Real-World Sotatercept Eligibility: Analysis from the FOCUS-PAH Registry.

Journal: Respiration; international review of thoracic diseases

Published: December 16, 2025

Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).

Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).

Journal: Vascular pharmacology

Published: November 13, 2025

Echocardiographic Estimation of Mean Pulmonary Artery Pressure: Head-to-Head Comparison of 5 Methods.

Echocardiographic Estimation of Mean Pulmonary Artery Pressure: Head-to-Head Comparison of 5 Methods.

Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Published: August 05, 2025

Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study.

Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study.

Journal: Vascular pharmacology

Published: June 10, 2025

Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study.

Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study.

Journal: BMJ open respiratory research

Published: May 14, 2025

Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis.

Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis.

Journal: Joint bone spine

Published: January 27, 2025

Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry.

Journal: International journal of cardiology

Published: December 14, 2024

Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension.

Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension.

Journal: Chest

Published: November 15, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026